R&D Center

R&D Center

Home /

Products/

R&D Center

R&D Team

R&D Team

Technical Inventor of the IPC
Professor Ji Xunming's Team, Xuanwu Hospital

Validated through large-scale clinical trials involving tens of thousands of patients, this pioneering remote ischemic preconditioning (RIPC) training device and its technological principles were first developed in China. The Xuan Yitong team has demonstrated proven clinical efficacy in stroke prevention, sleep improvement, blood pressure regulation, and cerebral small vessel disease management, establishing it as an innovative solution for cardiovascular and cerebrovascular disease prevention and treatment.

Scientific Research Awards

The team has established extensive and enduring academic partnerships with global institutions, including:National Institutes of Health (NIH), USA,Harvard University,Stanford University,Johns Hopkins University,University of California, San Francisco (UCSF),University of Pittsburgh.
Flagship National-Level Collaborative Programs:National Million Disability Reduction Project;National Cardiovascular & Cerebrovascular Disease Alliance;Beijing High-Altitude Adaptation & Rehabilitation Center;NASA Human Research Program;Canadian Centre for Health & Nephrology Research.

SCI Journal Papers

Scientific Research Awards

  • Research Patent

    10

    +

    10

    +

    Research Patent

    National Invention Patent (China), Japanese Invention Patent, US Invention Patent, Utility Model Patent (available in certain countries like China), Design Patent, etc.

  • National Awards

    5

    5

    National Awards

    Second Prize of National Science & Technology Progress Award，International Stroke Development & Innovation Award，Medical Industry Development & Innovation Award，China Medical Science & Technology Award，Ministry of Education Science & Technology Progress Award。

  • Chinese Domestic Professional Journals

    526

    526

    Chinese Domestic Professional Journals

    Publications in Chinese Domestic Zhonghua-Series Professional Journals

"Remote ischemic conditioning (RIC) induces endogenous cytoprotective pathways via humoral mediators (adenosine, bradykinin, NO, VEGF), which mitigate ischemia-reperfusion injury in critical organs. Clinical applications span cerebrovascular insufficiency, post-stroke recovery, and prophylaxis of atherosclerotic complications (Class IIa evidence, AHA/ASA Guidelines).

Customized

Our expert technical team is available 24/7 to resolve any product issues.
We guarantee prompt responses and strive for your utmost satisfaction.
Customized solutions are offered based on your operational scenarios and specific needs.
End-to-end service coverage: From product consultation to strategic partnerships.

Beijing Xuanyi Intelligent Technology Group Co., ltd

*Name

*Email

*Phone

*Address

*Question

Collection and Use of Personal Information I agree
400-8066-900

京ICP备2023036278号-1

Powered By CE ULTIMATE